Maternal diabetes and the role of neonatal reticulocyte hemoglobin content as a biomarker of iron status in the perinatal period

Maternal diabetes and the role of neonatal reticulocyte hemoglobin content as a biomarker of iron status in the perinatal period

AimsWe aimed to evaluate the effects of maternal diabetes on neonatal iron status, measuring erythrocyte indices including hemoglobin, hematocrit, reticulocytes, mean corpuscular volume (MCV), percent (%) hypochromia, ferritin, and additionally mean reticulocyte hemoglobin content (MCHr) as an early...

Full description

Bibliographic Details
Main Authors: Evgeniya Babacheva, Dimitrios Rallis, Helen Christou, George Mitsiakos, Themistoklis Mikos, Kalliopi Dampala, Christos Tsakalidis, Anna Kioumi, Dimitrios G. Goulis, Vasiliki Soubasi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Endocrinology
Subjects:
anemia
gestational diabetes
hypochromia
iron deficiency
reticulocytes
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.1011897/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.1011897/full

Similar Items